excellent in vitro antimalarial activities (IC90 (W2) down to 6.74 nM). The same entities also inhibit the botulinum neurotoxin serotype A light chain metalloprotease at low micromolar levels (7-31 microM). Interestingly, structural features imparting increased antimalarial activity also provide increased metalloprotease inhibition, thus allowing for simultaneous compound optimizations against distinct targets
我们报告了将
4-氨基-7-氯喹啉与甾体和
金刚烷成分偶联以提供具有出色的体外抗疟活性(IC90(W2)低至6.74 nM)的小分子的初步结果。相同的实体还以低微摩尔
水平(7-31 microM)抑制肉毒杆菌神经毒素血清型A轻链
金属
蛋白酶。有趣的是,赋予增加的抗疟活性的结构特征也提供了增加的
金属
蛋白酶抑制,因此允许针对不同靶同时进行化合物优化。